Susquehanna International Group, LLP Bluebird Bio, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 541,620 shares of BLUE stock, worth $173,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares

541,620

Previous 901,933 39.95%

Holding current value

$173,318

Previous $883,000 68.18%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.47 - $1.35 $169,347 - $486,422	-360,313 Reduced 39.95%	541,620 $281,000
Q2 2024 Aug 15, 2024	SELL	$0.85 - $1.26 $366,661 - $543,521	-431,366 Reduced 32.35%	901,933 $883,000
Q1 2024 May 07, 2024	SELL	$0.91 - $1.75 $137,016 - $263,494	-150,568 Reduced 10.15%	1,333,299 $1.71 Million
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $1.18 Million - $4.3 Million	890,521 Added 150.08%	1,483,867 $2.05 Million
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.05 $242,240 - $324,858	80,212 Added 15.63%	593,346 $1.8 Million
Q2 2023 Aug 11, 2023	SELL	$2.79 - $5.03 $2.16 Million - $3.9 Million	-775,685 Reduced 60.19%	513,134 $1.69 Million
Q1 2023 May 16, 2023	BUY	$3.14 - $8.22 $2.64 Million - $6.92 Million	841,766 Added 188.29%	1,288,819 $4.1 Million
Q4 2022 Feb 14, 2023	SELL	$5.77 - $8.49 $1.72 Million - $2.54 Million	-298,894 Reduced 40.07%	447,053 $3.09 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $392,782 - $774,043	104,742 Added 16.34%	745,947 $4.72 Million
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $901,665 - $1.6 Million	306,689 Added 91.68%	641,205 $2.66 Million
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $132,238 - $344,404	-32,491 Reduced 8.85%	334,516 $1.62 Million
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $492,665 - $896,805	54,985 Added 17.62%	367,007 $3.67 Million
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $493,256 - $921,564	-43,884 Reduced 12.33%	312,022 $5.96 Million
Q2 2021 Aug 11, 2021	SELL	$18.04 - $22.09 $3.22 Million - $3.94 Million	-178,317 Reduced 33.38%	355,906 $11.4 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $5.54 Million - $11.3 Million	334,074 Added 166.91%	534,223 $16.1 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $1.64 Million - $2.27 Million	59,787 Added 42.59%	200,149 $8.66 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $279,446 - $354,987	-8,114 Reduced 5.46%	140,362 $7.57 Million
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $150,760 - $255,547	5,559 Added 3.89%	148,476 $9.06 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $1.28 Million - $3.11 Million	-48,988 Reduced 25.53%	142,917 $6.57 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $134,305 - $176,376	2,860 Added 1.51%	191,905 $16.8 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $1.24 Million - $1.94 Million	-20,836 Reduced 9.93%	189,045 $17.4 Million
Q2 2019 Aug 16, 2019	BUY	$75.84 - $105.21 $301,160 - $417,788	3,971 Added 1.93%	209,881 $26.7 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $11.8 Million - $16.3 Million	155,017 Added 304.59%	205,910 $26.2 Million
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $9.94 Million - $16.1 Million	-154,208 Reduced 75.19%	50,893 $8.01 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $993,589 - $1.57 Million	16,812 Added 8.93%	205,101 $20.3 Million
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $13.3 Million - $17.5 Million	-149,346 Reduced 44.23%	188,289 $27.5 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $29.3 Million - $37.5 Million	293,985 Added 673.51%	337,635 $53 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $4.89 Million - $6.98 Million	-46,222 Reduced 51.43%	43,650 $7.45 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $6.1 Million - $9.81 Million	-75,062 Reduced 45.51%	89,872 $16 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $9.52 Million - $15.1 Million	164,934	164,934 $22.7 Million

Others Institutions Holding BLUE

# of Institutions

152

Shares Held

63.7M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $24.7M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Bluebird Bio, Inc. Transaction History